Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.
Also called NCT02200991
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 136 participants
- Sponsor
- Registry
-
NCT02200991
-
- Other papers using this trial's data
- Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02200991. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2015-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- LIXISENATIDE AVE0010
- Intervention (Drug)
- Sitagliptin
- Intervention (Drug)
- Insulin glargine HOE901
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02200991- Content hash
e7694687bba350a3151da37cff4660b31927fee70518bb77547ecf412b9808c4